Benea, O. E., Streinu-Cercel, A., Dorobăţ, C., Rugină, S., Negruţiu, L., Cupşa, A., . . . Iosif, I. (2014). Efficacy and safety of darunavir (Prezista(®)) with low-dose ritonavir and other antiretroviral medications in subtype F HIV-1 infected, treatment-experienced subjects in Romania: A post-authorization, open-label, one-cohort, non-interventional, prospective study. National Institute of Infectious Diseases “Prof. Dr. Matei Balş”, Romania, and the European Academy of HIV/AIDS and Infectious Diseases.
Trích dẫn kiểu ChicagoBenea, Otilia Elisabeta, et al. Efficacy and Safety of Darunavir (Prezista(®)) With Low-dose Ritonavir and Other Antiretroviral Medications in Subtype F HIV-1 Infected, Treatment-experienced Subjects in Romania: A Post-authorization, Open-label, One-cohort, Non-interventional, Prospective Study. National Institute of Infectious Diseases “Prof. Dr. Matei Balş”, Romania, and the European Academy of HIV/AIDS and Infectious Diseases, 2014.
Trích dẫn MLABenea, Otilia Elisabeta, et al. Efficacy and Safety of Darunavir (Prezista(®)) With Low-dose Ritonavir and Other Antiretroviral Medications in Subtype F HIV-1 Infected, Treatment-experienced Subjects in Romania: A Post-authorization, Open-label, One-cohort, Non-interventional, Prospective Study. National Institute of Infectious Diseases “Prof. Dr. Matei Balş”, Romania, and the European Academy of HIV/AIDS and Infectious Diseases, 2014.